S2k-Leitlinie Neurodermitis [atopisches Ekzem; atopische Dermatitis] – Kurzversion

  • Thomas Werfel
  • Annice Heratizadeh
  • Werner Aberer
  • Frank Ahrens
  • Matthias Augustin
  • Tilo Biedermann
  • Thomas Diepgen
  • Regina Fölster-Holst
  • Uwe Gieler
  • Julia Kahle
  • Alexander Kapp
  • Alexander Nast
  • Katja Nemat
  • Hagen Ott
  • Bernhard Przybilla
  • Martin Roecken
  • Martin Schlaeger
  • Peter Schmid-Grendelmeier
  • Jochen Schmitt
  • Thomas Schwennesen
  • Doris Staab
  • Margitta Worm

Abstract

Atopic dermatitis (AD) represents a pruritic, non-contagious, chronic or chronically relapsing, inflammatory skin disease. The course of the disease may be complicated by bacterial or viral superinfections. The first manifestation of the disease and further flare-ups are due to genetic predisposition and also to a variety of further trigger factors. The therapy regimen should be adapted to disease symptoms that are actually present and consider individual features of the disease as reported by the patients or their parents. This short version of the German guideline on AD provides an overview of evidence-based diagnostic and treatment options. All recommendations made here are the result of a consensus of the scientific medical societies, working groups and support groups based on scientific data published to date. Abstracts and details of the studies cited are provided in the long version of this guideline (see: www.awmf.org).

Bibliografische Daten

OriginalspracheDeutsch
ISSN1610-0379
DOIs
StatusVeröffentlicht - 01.2016
PubMed 26713654